Variation in Continence and Potency by Definition, The International Index of Erectile Function (IIEF), pp.1291-1294, 1997. ,
DOI : 10.1097/01.ju.0000085341.63407.46
[Evaluation of sexuality and erectile function of candidates for radical prostatectomy ,
[Questionnaires in sexual medicine The role of vacuum pump therapy to mechanically straighten the penis in Peyronie's disease Review of non-surgical treatment options for Peyronie's disease, Urol. Prog. En Urol. J. Assoc. Fr. Urol. Société Fr. Urol. BJU Int. Int. J, vol.16, issue.106 8, pp.450-456, 2006. ,
Current status and new developments in Peyronie's disease: medical, minimally invasive and surgical treatment options Peyronie's disease: review of nonsurgical treatment options, Expert Opin. Pharmacother. Urol. Clin, vol.24, issue.12 6, pp.1-10, 2011. ,
Medical management of Peyronie's disease, J. Androl, vol.38, issue.30 4, pp.195-205, 2011. ,
Non-surgical therapy of Peyronie's disease, Asian J. Androl, vol.10, issue.11, 2009. ,
Systematic evidence-based analysis of plaque injection therapy for Peyronie's disease Review of current nonsurgical management of Peyronie's disease, Eur. Urol. Int. J. Impot. Res, vol.1, issue.51 3, pp.79-87, 2007. ,
Advances in the medical therapy of Peyronie's disease: a brief review The use of collagenase in the treatment of Peyronie's disease Collagenase for Peyronie's disease experimental studies, Int. J. Impot. Res. J. Urol, vol.15, issue.134 2, pp.113-120, 1985. ,
Combination of penile traction, intralesional verapamil, and oral therapies for Peyronie's disease Penile traction therapy for treatment of Peyronie's disease: a single-center pilot study Extracorporeal shockwave therapy for Peyronie's disease: an alternative treatment? Long-term results of extracorporeal shockwave therapy for Peyronie's disease Extracorporeal shockwave therapy for, Urol. Res. J. Sex. Med. J. Sex. Med. Asian J. Androl. J. Endourol. Endourol. Soc, vol.10, issue.20 11, pp.135-140, 1982. ,
Comment on 'Topical verapamil HCL, topical trifluoroperazine, and topical magnesium sulfate for the treatment of Peyronie's disease--a placebo-controlled pilot study' A critical analysis of nonsurgical treatment of, J. Sex. Med, vol.41, issue.4 4, pp.113-118, 2007. ,
Combined treatment with vitamin E and colchicine in the early stages of ,
Tamoxifen versus placebo in the treatment of Peyronie's disease Peyronie's disease associated with increase in plasminogen activator inhibitor in fibrotic plaque, BJU Int. J. Urol. Urology, vol.91, issue.65 4, pp.522-524, 1999. ,
Oral propionyl-l-carnitine and intraplaque verapamil in the therapy of advanced and resistant Peyronie's disease, 29] W. Weidner, E. W. Hauck, J. Schnitker, and Peyronie's Disease Study Group of Andrological Group, pp.895-900, 2002. ,
DOI : 10.1007/BF00128246
Potassium paraaminobenzoate (POTABA) in the treatment of Peyronie's disease: a prospective, placebo-controlled, randomized study, L. Eisenberg, and T, pp.530-535, 2005. ,
Pentoxifylline treatment and penile calcifications in men with Peyronie's disease The management of Peyronie's disease: evidence-based 2010 guidelines, Asian J. Androl. J. Sex. Med, vol.13, issue.7 7, pp.322-325, 2011. ,
Open Preliminary Randomized Prospective Clinical Trial of Efficacy and Safety of Three Different Verapamil Dilutions for Intraplaque Therapy of Peyronie???s Disease, Urology, vol.69, issue.5, pp.950-954, 2007. ,
DOI : 10.1016/j.urology.2007.01.080
Effect of intralesional verapamil for treatment of Peyronie's disease: a randomized single-blind, placebo-controlled study, Urology Int. Urol, vol.69, issue.6, pp.1181-1184, 2007. ,
Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie's disease Effect of intralesional interferon-alpha 2b combined with oral vitamin E for treatment of early stage Peyronie's disease: a randomized and prospective study The use of collagenase in the treatment of Peyronie's disease M The use of intralesional clostridial collagenase injection therapy for Peyronie's disease: a prospective, single-center, non-placebo-controlled study, Collagenase versus placebo in the treatment of, pp.394-398, 2006. ,
Re: Clinical Efficacy, Safety and Tolerability of Collagenase Clostridium Histolyticum for the Treatment of Peyronie Disease in 2 Large Double-Blind, Randomized, Placebo Controlled Phase 3 Studies, The Journal of Urology, vol.191, issue.2, pp.56-58, 1993. ,
DOI : 10.1016/j.juro.2013.09.037
Circumcision is not mandatory in penile surgery Congenital curvature of the phallus: report of three cases with description of corrective operation Congenital curvature of the phallus: report of three cases with description of corrective operation The Nesbit operation for Peyronie's disease: 16-year experience Modified corporoplasty for the treatment of penile curvature Surgical treatment of Peyronie's disease: a critical analysis Color Doppler ultrasound assessment of penile vascular system in men with Peyronie's disease, J. Urol. BJU Int. Trans. Am. Assoc. Genitourin. Surg. J. Urol. J. Urol. J. Urol. Eur. Urol. Int. J. Impot. Res, vol.190, issue.12 5, pp.199-207, 1964. ,
Use of Small Intestinal Submucosa Graft for the Surgical Management of Peyronie???s Disease, The Journal of Urology, vol.178, issue.6 ,
DOI : 10.1016/j.juro.2007.08.044
Surgical Atlas Correction of, J. Urol, vol.178, issue.2478, pp.2474-2478, 2007. ,
Peyronie's reconstruction for maximum length and girth gain: geometrical principles [Ultrasonographic study of Peyronie's disease] Risk factors for emotional and relationship problems in Peyronie's disease The chronology of depression and distress in men with Peyronie's disease, 54] C. Muyshondt and Faix, pp.1353-1360, 2000. ,
26 I.2.1 Cours théoriques, p.26 ,